Patent application number | Description | Published |
20120321656 | OLIGOPEPTIDES AND THEIR USE FOR TREATING INFECTIOUS DISEASES - The invention discloses identification, method of making and therapeutic use of synthetic oligopeptides for the treatment of infectious diseases, in particular tuberculosis. The oligopeptides are designed using virulence mediating protein for | 12-20-2012 |
20130011423 | METALLOPROTEINASE OLIGOPEPTIDES AND THEIR THERAPEUTIC USE - The invention discloses identification and therapeutic use of matrix metalloproteinase oligopeptides, SEQID 5-SEQID 21. These oligopeptides are bound to antibodies to create an immune response in the subject mammal against the matrix metalloproteinases of various diseases. This is a means of therapeutic intervention against the disease spread created by the matrix metalloproteinases. Further use of these oligopeptide-antibody responses can be extended to any and all diseases that use the matrix metalloproteinases to aid in their pathogenicity. | 01-10-2013 |
20130040273 | INTEGRATED MULTIMEDIA TOOL SYSTEM AND METHOD TO EXPLORE AND STUDY THE VIRTUAL HUMAN BODY - Several methods, processes and system for modular tool as an integrated multimedia tool system to explore and study the virtual human body is disclosed. Content and context modules allow for scientific gaming using modular multimedia objects, social media and different configurations. The disclosure allows an individual to travel through the virtual human body in a self guided and interactive tour. It specifically enables the user to learn the structure and function of different organs, different types of cells, intercellular space as well as different cellular organelles etc. Further, the system may be used by the local authority as an electronic study tool for seamless integrated mode of delivering the educational tool suited to the local curriculum. This may also serve as a tool for patients, doctors, focus groups and student to explore and learn about the pathological and physiological conditions in a human body. | 02-14-2013 |
20130040274 | INTEGRATED INTERACTIVE SYSTEM AND METHOD FOR VISUALIZING HUMAN PHYSIOLOGY, DISEASE, TREATMENT OPTIONS AND USE - A novel integrated system and method for visualizing human physiology, disease and treatment options are described in the instant application. The graphical rendering of the human body is in depth and the user can explore the internal workings of the organs and cells by simply performing a pealing like act using a cursor and the layer as a flap opens up to show the details. A user can click on a specific topic and watch a video, narration or text relevant to the topic of choice. The integrated system provides storage of curated data, social media access and interaction, database storage and analytics to calculate user behavior. This technology may used as an application on any mobile and hardware device. | 02-14-2013 |
20140017225 | METALLOPROTEINASE-9 OLIGOPEPTIDES AND THEIR THERAPEUTIC USE - The invention discloses identification and therapeutic use of matrix metalloproteinase oligopeptides, SEQ ID wherein the matrix metalloproteinase oligopeptide is at least one of SEQ ID 7, 11, 12, 18 and 19 and combination thereof. These oligopeptides are bound to antibodies to create an immune response in the subject mammal against the matrix metalloproteinases of various diseases. The instance method is a means of therapeutic intervention against the disease spread created by the matrix metalloproteinases. Further use of these oligopeptide-antibody responses can be extended to any and all diseases that use the matrix metalloproteinases to aid in their pathogenicity. | 01-16-2014 |
20140017267 | METALLOPROTEINASE OLIGOPEPTIDES AND THEIR THERAPEUTIC USE - The invention discloses identification and therapeutic use of matrix metalloproteinase oligopeptides, SEQ ID 5-SEQ ID 21. These oligopeptides are bound to antibodies to create an immune response in the subject mammal against the matrix metalloproteinases of various diseases. This is a means of therapeutic intervention against the disease spread created by the matrix metalloproteinases. Further use of these oligopeptide-antibody responses can be extended to any and all diseases that use the matrix metalloproteinases to aid in their pathogenicity. | 01-16-2014 |
20150074835 | TRANSGENIC MOUSE EXPRESSING HUMAN LIPOPROTEIN (A) WITH DISABLED VITAMIN C GENE AND ITS USE AS A DISEASE TREATMENT MODEL - The invention discloses novel model of transgenic mammal, a method of crossbreeding transgenic mammal and the use of the transgenic mammal for assessing prevention and/or treatment methods for cardiovascular and other diseases related to lipoprotein(a). The transgenic mammal expresses human apolipoprotein (a) (apo(a)) and human apolipoprotein B-100 (apo B-100) genes and produces human lipoprotein (a), apo (a) and apo B-100 and produces no vitamin C. This novel dual transgenic mammal is the ideal model for testing pharmaceutical compounds for efficacy and usefulness in the prevention and/or treatment of human diseases. | 03-12-2015 |
20150074837 | Transgenic mouse expressing human apo(a) and human apo(B-100) with disabled vitamin C gene produces human Lp(a) - The invention discloses novel model of transgenic mammal, a method of crossbreeding transgenic mammal and the use of the transgenic mammal for assessing prevention and/or treatment methods for cardiovascular and other diseases related to lipoprotein(a). The transgenic mammal expresses human apolipoprotein (a) (apo(a)) and human apolipoprotein B-100 (apo B-100) genes and produces human lipoprotein (a), apo (a) and apo B-100 and produces no vitamin C. This novel dual transgenic mammal is the ideal model for testing pharmaceutical compounds for efficacy and usefulness in the prevention and/or treatment of human diseases. | 03-12-2015 |